首页 | 本学科首页   官方微博 | 高级检索  
     


Apremilast for the treatment of moderate‐to‐severe palmoplantar psoriasis: results from a double‐blind,placebo‐controlled,randomized study
Authors:R. Bissonnette  R. Haydey  L.A. Rosoph  C.W. Lynde  M. Bukhalo  J.F. Fowler  I. Delorme  A. Gagné‐Henley  M. Gooderham  Y. Poulin  K. Barber  P. Jenkin  I. Landells  D.M. Pariser
Affiliation:1. Innovaderm Research, Montreal, QC, Canada;2. Winnipeg Clinic, Winnipeg, MB, Canada;3. North Bay Dermatology Centre, North Bay, ON, Canada;4. Lynderm Research, Markham, ON, Canada;5. Altman Dermatology Associates, Arlington Heights, IL, USA;6. Dermatology Specialists Research, Louisville, KY, USA;7. Dr Isabelle Delorme Inc., Drummondville, QC, Canada;8. Dre Angélique Gagné‐Henley MD Inc., Saint‐Jér?me, QC, Canada;9. Dr. Melinda Gooderham SKiN Centre for Dermatology, Peterborough, ON, Canada;10. Centre de Recherche Dermatologique du Québec Métropolitain, Québec, QC, Canada;11. Kirk Barber Research, Calgary, AB, Canada;12. Dermatology Associates, Seattle, WA, USA;13. Nexus Clinical Research, St. John's, NL, Canada;14. Department of Dermatology, Eastern Virginia Medical School and Virginia Clinical Research Inc., Norfolk, VA, USA
Abstract:
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号